NP Life Sciences Health Industry Group Inc. (ACAT) stock

ACATOTCServices-Educational ServicesFiscal year ends December 31

Financials through Q4 FY2023, quarter ended Dec 31, 2023Last filing: 10-K on Apr 16, 2024

$10.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $429.60MP/E –Yield –

NP Life Sciences Health Industry statistics

29 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Dec 31, 2023
Share price as of: –

Share statisticsIndustry

Shares Outstanding: 43M; 23M
Shares Change (YoY): 0.00%; 0.13%
Float: 43M; 22M
Shares Held by Insiders: 0.00%; 15.8%

MarginsIndustry

Operating Margin: -0.42%; -5.92%
Pretax Margin: -0.81%; -2.84%
Profit Margin: -1.78%; -8.26%
EBITDA Margin: -0.42%; -3.83%

Returns on capitalIndustry

Return on Equity (ROE): -15.2%; -0.07%
Return on Assets (ROA): -2.87%; -2.87%
Return on Capital Employed (ROCE): -1.78%; -1.78%

Financial positionIndustry

Quick Ratio: 1.85; 0.86
Interest Coverage: -1.07; 7.19

GrowthIndustry

Revenue Growth (YoY): 61.4%; 2.95%
Revenue Growth (3Y CAGR): 122.2%; 6.72%

EfficiencyIndustry

Asset Turnover: 1.61; 0.83

Income statement (TTM)Industry

Revenue: $164.62K; $80.66M
Operating Income: -$690; -$46.58K
Pretax Income: -$1.34K; -$27.47K
Net Income: -$2.94K; -$27.47K
EBITDA: -$690; -$46.58K
EPS (Diluted): $0.00; $0.00

Balance sheetIndustry

Cash & Short-Term Investments: $70.61K; $17.34M
Net Cash (Debt): $70.61K; $1.01M
Net Cash Per Share: $0.00; $0.07

Cash flow (TTM)Industry

Operating Cash Flow: -$73.61K; $40.74K

Taxes and interestIndustry

Interest Expense: $645; $2.24M
Income Tax: $1.60K; $1.27M

Scores and fair valueIndustry

Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

Period	ACAT	S&P 500	Difference	ACAT per year	S&P 500 per year
1 month	0.0%	+0.6%	−0.6 pts
3 months	0.0%	+3.4%	−3.4 pts
Year to date	0.0%	+13.3%	−13.3 pts
1 year	+1755.3%	+16.6%	+1738.7 pts
3 years	+96.1%	+86.4%	+9.7 pts	+25.2%	+23.1%
5 years	+96.1%	+81.9%	+14.2 pts	+14.4%	+12.7%

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

Where these numbers come from

Parsed from the XBRL in NP Life Sciences Health Industry's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Oct 28, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACAT.

Compare: ACAT vs EDU · ACAT vs AACG · ACAT vs EEIQ · ACAT vs KPEA · ACAT vs ZCMD

Revenue growth61.4% · median -30.9%

Operating margin-0.4% · median -122.4%

Net margin-1.8% · median -121.9%

Company	Revenue	Growth
AACG	CN¥268.11M	+0.0%
KPEA	$593.24K	-61.8%
ACAT	$164.62K	+61.4%
EDU	–	–
EEIQ	–	–
ZCMD	–	–

Company

Exchange: OTC
Industry: Services-Educational Services
Fiscal year ends: December 31
Auditor: WWC, P.C.
SEC CIK: 1781726

Advertisement
300 × 250

See a number that looks wrong?